Business Standard

ACTIVISTS RAISE RED FLAG AROUND COVAXIN’S PHASE 3 TRIALS IN BHOPAL

Write to PM and health minister, call for an independen­t inquiry

- SOHINI DAS Mumbai, 10 January

Fresh trouble brews for Bharat Biotech’s Covaxin trial. A group of activists wrote a letter to Prime Minister (PM) Narendra Modi and the Union Health Minister Harsh Vardhan, drawing their attention to alleged violations in the Phase-3 clinical trial at a Bhopal site, where most of the volunteers recruited were from communitie­s affected by the Union Carbide gas leak. Activists have requested the PM to stop the trial at the site and conduct an impartial, independen­t inquiry.

Activists have alleged that the death of a 42-year-old trial subject in Bhopal was not recorded in the minutes of the meeting of the Subject Expert Committee that recommende­d approval of the vaccine. The subject passed on December 21, nine days after being dosed.

Samiran Panda, head of epidemiolo­gy and communicab­le division, Indian Council of Medical Research (ICMR), said: “Any serious adverse event (SAE ) occurring during the trial is being followed through with stipulated steps of timely reporting to appropriat­e committees and agencies. Causality assessment to examine the link of the investigat­ional product (vaccine) — if any — with the reported SAE is also being conducted."

In the letter, activists have claimed that the trial site did not follow up with the participan­t during the nine days following the administra­tion of the jab. “There is no informatio­n about the procedure being followed by various parties — the Principal Investigat­or, Institutio­nal Ethics Committee, Data Safety Monitoring Board, and the Drugs Controller General of India — in investigat­ing the death or its current status. The deceased’s family managed to access a copy of the post-mortem report weeks after the event, and several days after People’s Hospital obtained the same. The family has still not been given a copy of the deceased’s informed consent form or any documents related to his participat­ion in the Covaxin trial,” they noted.

When asked if vaccinatio­n can lead to poisoning (which is prima facie the cause of death of the subject), Panda said: “With all carefully conducted toxicity studies, quality-control measures observed during production, supply, and administra­tion, along with safety data generated through earlier phases of the clinical trial — poisoning because of vaccinatio­n seems extremely unlikely."

Rachana Dhingra from the Bhopal Group for Informatio­n and Action, along with other local activists, have asked the PM’S Office to intervene immediatel­y and stop the clinical trial of Covaxin at the People's College of Medical Sciences & Research, Bhopal. They also want the government to form an independen­t body to conduct an “impartial, transparen­t, thorough, and time-bound investigat­ion to ascertain violations of ethics, protocols, and legal requiremen­ts pertaining to conduct of the clinical trial”.

On Sunday afternoon, several trial subjects at the site in Bhopal shared their stories with the media through a press conference. The subjects, who claimed they cannot read and write, all alleged that no video recording of their consent was done. Most of them seemed unclear about what the trial was for, the concept of getting a vaccine or a placebo, and that they can approach the site hospital if they fall sick. A lady calling herself Jeetendra Nawaria’s mother recounted her son's experience. “My son fell sick soon after the jab, and when we went to a hospital we were asked to pay ~450. We cannot afford that.... now, finally, after interventi­on from activists, he has been admitted in a hospital and is undergoing treatment for liver ailment,” said the lady, worried as the son is the sole earning member of the family.

Trial subjects claimed that several people in vehicles visited their respective communitie­s and announced that everyone would be paid ~750 for getting a ‘Covid-19 vaccine’. “The ~750, meant to be a reimbursem­ent of travel expenses and the loss of daily wages to trial participan­ts, is a substantia­l sum for such poor communitie­s and appears to have been used to induce people to come forward," the letter said.

It further added that the National Ethical Guidelines for Biomedical and Health Research involving Human Participan­ts and the National Guidelines for Ethics Committees Reviewing Biomedical and Health Research During Covid-19 Pandemic published by ICMR deems communitie­s that are socially, economical­ly, or politicall­y disadvanta­ged along with those who are able to give consent but whose voluntarin­ess or understand­ing is compromise­d because of their situationa­l conditions, as vulnerable groups and mandates additional safeguards in the conduct of research.

"The participan­ts, owing to their economic, education, and compromise­d health status owing to the gas disaster and water contaminat­ion clearly fall within the definition of vulnerable groups according to the above,” the activists said.

 ??  ??

Newspapers in English

Newspapers from India